189 companies

Amphastar Pharmaceuticals

Market Cap: US$842.2m

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

AMPH

US$19.30

7D

6.3%

1Y

-24.7%

Verastem

Market Cap: US$373.5m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

VSTM

US$4.29

7D

0.5%

1Y

-44.8%

Zevra Therapeutics

Market Cap: US$647.3m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

ZVRA

US$11.40

7D

8.7%

1Y

32.3%

High Tide

Market Cap: CA$290.1m

Engages in the cannabis retail business in Canada, the United States, and internationally.

HITI

CA$3.44

7D

2.1%

1Y

13.9%

Tasly Pharmaceutical Group

Market Cap: CN¥21.0b

Engages in the research, development, production, and sale of pharmaceuticals in China.

600535

CN¥14.07

7D

-0.8%

1Y

-13.8%

Caris Life Sciences

Market Cap: US$4.3b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

CAI

US$16.67

7D

4.6%

1Y

n/a

Arcutis Biotherapeutics

Market Cap: US$2.6b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

ARQT

US$21.44

7D

2.0%

1Y

56.8%

Cipher Pharmaceuticals

Market Cap: CA$420.8m

Operates as a specialty pharmaceutical company in Canada.

CPH

CA$16.51

7D

-2.2%

1Y

33.1%

Regeneron Pharmaceuticals

Market Cap: US$63.9b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

REGN

US$621.52

7D

-3.3%

1Y

2.7%

CorMedix

Market Cap: US$661.3m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

CRMD

US$8.42

7D

5.5%

1Y

-30.6%

Innovent Biologics

Market Cap: HK$144.9b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

New

1801

HK$83.35

7D

3.0%

1Y

34.5%

Kissei Pharmaceutical

Market Cap: JP¥161.2b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

4547

JP¥3,890.00

7D

-6.4%

1Y

-9.3%

Sanofi

Market Cap: €91.6b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

SAN

€75.29

7D

-2.1%

1Y

-14.0%

Elanco Animal Health

Market Cap: US$11.8b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

ELAN

US$23.98

7D

12.5%

1Y

77.4%

Alembic Pharmaceuticals

Market Cap: ₹144.7b

An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.

APLLTD

₹736.10

7D

-2.6%

1Y

-27.7%

Dong-A Socio Holdings

Market Cap: ₩598.6b

Engages in the pharmaceutical business in South Korea.

A000640

₩90,300.00

7D

-2.5%

1Y

-16.9%

Yunnan Baiyao GroupLtd

Market Cap: CN¥89.1b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

000538

CN¥49.94

7D

0.3%

1Y

-11.6%

Shanghai Fosun Pharmaceutical (Group)

Market Cap: CN¥56.8b

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

600196

CN¥23.25

7D

-0.6%

1Y

-8.4%

Bayer

Market Cap: €37.2b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

BAYN

€36.53

7D

-5.1%

1Y

47.7%

Hugel

Market Cap: ₩2.7t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

A145020

₩248,500.00

7D

-7.1%

1Y

-25.2%

Collegium Pharmaceutical

Market Cap: US$1.1b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

COLL

US$33.37

7D

-3.1%

1Y

14.4%

Ardelyx

Market Cap: US$1.5b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARDX

US$6.25

7D

-1.6%

1Y

55.1%

Dong-E-E-Jiao

Market Cap: CN¥32.1b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

000423

CN¥49.99

7D

0.9%

1Y

-8.8%

Bavarian Nordic

Market Cap: DKK 14.3b

Develops, manufactures, and supplies life-saving vaccines.

BAVA

DKK 188.00

7D

-4.6%

1Y

8.7%

Diaceutics

Market Cap: UK£120.2m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

New

DXRX

UK£1.43

7D

-14.1%

1Y

4.0%

Tarsus Pharmaceuticals

Market Cap: US$2.6b

A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.

TARS

US$59.54

7D

-6.2%

1Y

37.1%

Fennec Pharmaceuticals

Market Cap: US$346.3m

Operates as a commercial stage biopharmaceutical company in the United States.

FENC

US$9.89

7D

-0.8%

1Y

22.1%

Journey Medical

Market Cap: US$164.9m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

DERM

US$6.20

7D

-0.2%

1Y

-23.2%

Decibel Cannabis

Market Cap: CA$72.1m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

DB

CA$0.12

7D

-7.7%

1Y

84.6%

Genscript Biotech

Market Cap: HK$29.9b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

1548

HK$13.68

7D

5.5%

1Y

6.7%

Amoy Diagnostics

Market Cap: CN¥7.9b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.

300685

CN¥20.41

7D

7.6%

1Y

-2.2%

Dong-A ST

Market Cap: ₩384.5b

Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.

A170900

₩40,000.00

7D

-4.5%

1Y

-13.4%

Nanjing King-Friend Biochemical PharmaceuticalLtd

Market Cap: CN¥13.1b

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

603707

CN¥8.08

7D

-1.6%

1Y

-28.2%

Duopharma Biotech Berhad

Market Cap: RM 1.2b

Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.

DPHARMA

RM 1.22

7D

-3.2%

1Y

-14.1%

Exagen

Market Cap: US$121.0m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

XGN

US$5.08

7D

19.0%

1Y

-27.2%

Perrigo

Market Cap: US$1.5b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

PRGO

US$11.44

7D

0.8%

1Y

-57.8%

Page 1 of 6